Latest Articles
Model Barbara Palvin, 32, Shares Heartbreaking Endometriosis Details - The Daily Beast
Model Barbara Palvin, 32, Shares Heartbreaking Endometriosis Details The Daily Beast
Published: July 17, 2026, 12:15 a.m.
Endometriosis presents symptom patterns that go beyond pain - Medical Xpress
Endometriosis presents symptom patterns that go beyond pain Medical Xpress
Published: July 16, 2026, 11:20 p.m.
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial - BioPharm International
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial BioPharm International
Published: July 16, 2026, 9:06 p.m.
Prescribed opioids led to addiction for woman battling endometriosis - ABC News & Headlines – Australian Broadcasting Corporation
Prescribed opioids led to addiction for woman battling endometriosis ABC News & Headlines – Australian Broadcasting Corporation
Published: July 16, 2026, 8 p.m.
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools - Niagara Falls Review
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools Niagara Falls Review
Published: July 16, 2026, 7:32 p.m.
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools - Penticton Herald
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools Penticton Herald
Published: July 16, 2026, 7:32 p.m.
Endometrial Ablation Devices Market size to Reach USD 1.62 - openPR.com
Endometrial Ablation Devices Market size to Reach USD 1.62 openPR.com
Published: July 16, 2026, 5:35 p.m.
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily
Published: July 16, 2026, 4:40 p.m.
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools - St. Catharines Standard
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools St. Catharines Standard
Published: July 16, 2026, 3:47 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Link copied to clipboard!